Article Details

AstraZeneca's Enhertu shows promise for broader breast cancer use | Reuters

Retrieved on: 2022-02-21 08:26:46

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Enhertu shows promise for broader breast cancer use | Reuters. View article details on hiswai:

Excerpt

... challenging the world's biggest cancer drug maker, Roche. ... leads to uncontrolled tissue growth, when compared to Roche's ADC drug Kadcyla.

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up